SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The sales slipped to Rs. 3191.50 millions for the June 2025 quarter as against Rs. 3634.90 millions during the year-ago period.The Total Profit for the quarter ended June 2025 of Rs. 105.30 millions grew from Rs.-123.20 millionsThe company reported a good operating profit of 580.10 millions compared to 436.20 millions of corresponding previous quarter.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202506 202406 % Var 202506 202406 % Var 202503 202403 % Var
Sales 3191.50 3634.90 -12.20 3191.50 3634.90 -12.20 12837.60 12889.20 -0.40
Other Income 9.80 13.80 -28.99 9.80 13.80 -28.99 91.40 53.70 70.20
PBIDT 580.10 436.20 32.99 580.10 436.20 32.99 2129.80 -896.90 -337.46
Interest 239.00 308.70 -22.58 239.00 308.70 -22.58 1148.10 1059.70 8.34
PBDT 341.10 127.50 167.53 341.10 127.50 167.53 981.70 -3853.00 -125.48
Depreciation 235.80 250.70 -5.94 235.80 250.70 -5.94 992.50 1030.30 -3.67
PBT 105.30 -123.20 -185.47 105.30 -123.20 -185.47 -10.80 -4883.30 -99.78
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 785.40 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 785.40 0.00
PAT 105.30 -123.20 -185.47 105.30 -123.20 -185.47 -10.80 -5668.70 -99.81
Equity 443.40 402.10 10.27 443.40 402.10 10.27 402.50 360.00 11.81
PBIDTM(%) 18.18 12.00 51.47 18.18 12.00 51.47 16.59 -6.96 -338.42

Solara Active Pharma Share Price

486.70 -7.00 (-1.42%)
16-Apr-2026 10:05 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1692.90
Dr. Reddys Lab 1220.70
Cipla 1229.70
Zydus Lifesciences 938.90
Lupin 2319.85
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×